July 1, 2022
From the desk of Dividend Press
Dear Reader,
We have identified several stocks which are expected to go “Ex-Dividend” very soon.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Press Report:
JPMorgan Chase & Co.
Symbol: JPM
Recent Price: $112.61
Average Analyst Price Target: $154.44 (37.74%)
Market Cap: $330.74B
Expected Ex-Dividend Date: Jul 05 2022
Expected Payment Date: Jul 31 2022
Expected Dividend & Yield: 3.38%
Recent Analyst Action: Jeff Harte, analyst at Piper Sandler, reiterates coverage on JPMorgan Chase & Co. (JPM) in the Financial sector with a Buy rating and a price target of $ 158 (12 hours ago).
TipRanks.com also reports that JPMorgan Chase & Co. currently has 19 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $154.44 . The target pricing ranges from a high forecast of $200.00 down to a low forecast of $120.00. JPMorgan Chase & Co. (JPM)’s last closing price was $112.61 which would put the average price target at 37.74% upside.Here are 3rd party ratings for JPM:
Recent Analyst Action: Brian Tanquilut, analyst at Jefferies, reiterates coverage on Quest Diagnostics (DGX) in the Healthcare sector with a Hold rating and a price target of $ 135 (1 week ago).
TipRanks.com also reports that Quest Diagnostics currently has 9 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $153.75 . The target pricing ranges from a high forecast of $185.00 down to a low forecast of $135.00. Quest Diagnostics (DGX)’s last closing price was $132.98 which would put the average price target at 15.62% upside.Here are 3rd party ratings for DGX:
Recent Analyst Action: Juan C., analyst at BMO Capital, reiterates coverage on Healthcare Trust of America (HTA) in the Financial sector with a Hold rating and a price target of $ 29 (1 week ago).
TipRanks.com also reports that Healthcare Trust of America currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $31.50 . The target pricing ranges from a high forecast of $34.00 down to a low forecast of $29.00. Healthcare Trust of America (HTA)’s last closing price was $27.91 which would put the average price target at 12.86% upside.Here are 3rd party ratings for HTA:
Recent Analyst Action: Sami Badri, analyst at Credit Suisse, reiterates coverage on Cisco Systems (CSCO) in the Technology sector with a Buy rating and a price target of $ 60 (2 weeks ago).
TipRanks.com also reports that Cisco Systems currently has 20 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $52.17 . The target pricing ranges from a high forecast of $71.00 down to a low forecast of $40.00. Cisco Systems (CSCO)’s last closing price was $42.64 which would put the average price target at 22.35% upside.Here are 3rd party ratings for CSCO:
Recent Analyst Action: Jonathan Kees, analyst at Daiwa, reiterates coverage on Comcast (CMCSA) in the Services sector with a Buy rating and a price target of $ 43 (12 hours ago).
TipRanks.com also reports that Comcast currently has 18 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $51.25 . The target pricing ranges from a high forecast of $60.00 down to a low forecast of $40.00. Comcast (CMCSA)’s last closing price was $39.24 which would put the average price target at 30.61% upside.Here are 3rd party ratings for CMCSA:
Recent Analyst Action: Michael R, analyst at Truist Financial, reiterates coverage on Cousins Properties (CUZ) in the Financial sector with a Hold rating and a price target of $ 33 (1 day ago).
TipRanks.com also reports that Cousins Properties currently has 6 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $39.60 . The target pricing ranges from a high forecast of $45.00 down to a low forecast of $33.00. Cousins Properties (CUZ)’s last closing price was $29.23 which would put the average price target at 35.48% upside.Here are 3rd party ratings for CUZ:
Recent Analyst Action: Michael R, analyst at Truist Financial, reiterates coverage on Brandywine Realty (BDN) in the Financial sector with a Hold rating and a price target of $ 11 (1 day ago).
TipRanks.com also reports that Brandywine Realty currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $11.75 . The target pricing ranges from a high forecast of $14.00 down to a low forecast of $10.00. Brandywine Realty (BDN)’s last closing price was $9.64 which would put the average price target at 21.89% upside.Here are 3rd party ratings for BDN:
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
Dividend Press is a Delray Research Publication.
Delray Research is powered by our content partners at TipRanks, BarChart, and TradingView.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
Dividend Press
DelrayResearch is an independent research and information publisher that aggregates data from multiple sources and publishes reports for your reading pleasure. Make sure to always do your own research and due diligence. DelrayResearch is not a licensed professional.